As is clear from my other posts, I am a proponent of metformin. I think it is safe and benefits almost all people - especially bodybuilders eating a lot and using drugs that reduce insulin sensitivity (like GH). However, one lingering question remains for me...
We know the bulk of the life extension / anti-cancer benefits of Metformin come from its systematic reduction in IGF-1. Where you see lower IGF-1, you see lower rates of cancer and slower cancer progress in general. Calorie restriction and lowered IGF-1 are reoccurring themes in the "life extension" puzzle. When we introduce exo GH, it is converted in the liver (in varying rates depending on the person and also liver health) to IGF-1. The main benefits from GH come from a prolonged increase in circulated IGF-1 levels. If your IGF-1 levels are not up, you will not see the results from GH you are looking for. So if we are diminishing our IGF-1 conversion with metformin, are we losing a lot of the benefit of exo GH use? It would be a fair assumption to say that 1g of metformin use a day will reducing IGF-1 levels, but to what degree? Enough that it would render 4iu of exo GH a waste of money, or would the slight reduction in IGF-1 be negligible in athletes using GH? All of the studies showing IGF-1 reduction from Metformin are from normal, non-enhanced people NOT taking no AAS or GH. Im curious what the implications are for IGF-1 levels when co-administering exo GH, AAS and Metformin. My guess is you still come out ahead but that your IGF-1 may take a slight dip.
Thoughts?